Oppenheimer Inc. (OPY)
NYSE: OPY
· Real-Time Price · USD
71.76
0.96 (1.36%)
At close: Oct 03, 2025, 3:59 PM
71.69
-0.10%
After-hours: Oct 03, 2025, 05:29 PM EDT
1.36% (1D)
| Bid | 70 |
| Market Cap | 747.8M |
| Revenue (ttm) | 1.49B |
| Net Income (ttm) | 87.57M |
| EPS (ttm) | 7.57 |
| PE Ratio (ttm) | 9.48 |
| Forward PE | 85.28 |
| Analyst | n/a |
| Dividends | $0.72 |
| Ask | 75 |
| Volume | 47,798 |
| Avg. Volume (20D) | 51,836 |
| Open | 70.79 |
| Previous Close | 70.80 |
| Day's Range | 69.91 - 71.76 |
| 52-Week Range | 47.39 - 79.99 |
| Beta | 1.17 |
| Ex-Dividend Date | Aug 15, 2025 |
5 months ago
+0.9%
Shares of financial companies are trading higher a...
Unlock content with
Pro Subscription
5 months ago
+1.78%
Shares of financial companies are trading higher amid Treasury Secretary Scott Bessent's remarks about trade de-escalation with China, which may help restore investor confidence towards the sector.
2 months ago · https://thefly.com
Y-mAbs Therapeutics downgraded to Perform from Outperform at OppenheimerOppenheimer analyst Jeff Jones downgraded Y-mAbs Therapeutics without a price target to Perform from Outperform after the company agreed to be acquired by SERB Pharmaceuticals for $8.60 per share in c...
2 months ago · businesswire.com
Cognyte to Participate in Oppenheimer's 28th Annual Technology, Internet & Communications ConferenceHERZLIYA, Israel--(BUSINESS WIRE)--Cognyte's CEO and CFO will present at Oppenheimer's 28th Annual Technology, Internet & Communications Conference on August 13, 2025 at 12:25 p.m. ET.